The treatment of bleomycin-induced lung injury with combination of antioxidants and interleukin-1 receptor antagonist (IL-1ra) Source: Eur Respir J 2002; 20: Suppl. 38, 488s Year: 2002
Steroids induce a disequilibrium of secreted interleukin-1 receptor antagonist and interleukin-1? synthesis by human neutrophils Source: Eur Respir J 2011; 37: 406 Year: 2011
Use of interleukin-1beta (IL-1beta) and interleukin-1 receptor antagonist (IL-1Ra) contents in alveolar macrophages for estimation of inflammation activity in patients with different levels of asthma control Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection Year: 2013
Interleukin-1b and interleukin-1 receptor antagonist gene polymorphisms in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: Suppl. 48, 136s Year: 2004
Interleukin-1 receptor-related protein ST2 suppresses the initial stage of bleomycin-induced lung injury Source: Eur Respir J 2009; 33: 1415-1428 Year: 2009
Prevention of oxidative stress in rats exposed to industrial dust with interleukin-1 receptor antagonist (IL-1ra) Source: Eur Respir J 2001; 18: Suppl. 33, 445s Year: 2001
Synthetic cannabinoids induce acute lung inflammation via cannabinoid receptor 1 activation Source: ERJ Open Res, 6 (3) 00121-2020; 10.1183/23120541.00121-2020 Year: 2020
Effects of a leukotriene B4 receptor antagonist on bleomycin-induced pulmonary fibrosis Source: Eur Respir J 2009; 34: 1444-1451 Year: 2009
SCH527123, a novel CXCR2 antagonist, inhibits ozone-induced neutrophilia in healthy subjects Source: Eur Respir J 2010; 35: 564-570 Year: 2010
The role of purinergic P2X7 receptors on lipopolysaccharide (LPS)-induced lung injury Source: Annual Congress 2007 - Acute and chronic lung injury and its repair: novel molecular insight Year: 2007
Abrogation of bleomycin induced inflammation and lung fibrosis by angiotensin AT1 receptor antagonist. Relevance of PGE-2 modulation Source: Eur Respir J 2005; 26: Suppl. 49, 82s Year: 2005
Inhaled CCR1 antagonist AZD4818 reduces leucocyte influx in the rat lipopolysaccharide (LPS) lung inflammation model Source: Annual Congress 2009 - Preclinical models in drug development Year: 2009
Preserved compliance and reduced inflammation after activation of peroxisome proliferator-activated receptor (PPAR)a in a murine model of acute lung injury Source: Annual Congress 2006 - Novel pathogenic aspects of acute lung injury and acute respiratory distress syndrome (ARDS) Year: 2006
Susceptibility to chronic bacterial purulent rhinosinusitis is associated with the combination of interleukin-1 beta and interleukin-1 receptor antagonist gene polymorphic alleles Source: Eur Respir J 2005; 26: Suppl. 49, 406s Year: 2005
Role of interleukin-1 receptor 1/MyD88 signalling in the development and progression of pulmonary hypertension Source: Eur Respir J 2016; 48: 470-483 Year: 2016
Immunomodulatory function of chemerin and its receptor ChemR23 in the physiopathology of viral pneumonia and acute lung injury Source: Annual Congress 2011 - Lung cell injury and repair Year: 2011
Protective effect of cysteinyl leukotriene receptor antagonist montelukast in bleomycin induced pulmonary fibrosis Source: Eur Respir J 2007; 30: Suppl. 51, 111s Year: 2007
Inhibitory effect of PGE2 receptor subtype, EP4, in bleomycin-induced pulmonary fibrosis Source: Annual Congress 2007 - Mechanisms of injury and repair in fibrotic, idiopathic or infectious lung disease Year: 2007
Enhanced expression of IL-18 receptor but not soluble form of IL18R in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2011 - COPD: clinical studies and animal cell models Year: 2011
Interleukin-18, interleukin-12, interferon γ and interleukin-18 receptor expression is decreased in the recovery phase of pulmonary sarcoidosis Source: Eur Respir J 2001; 18: Suppl. 33, 366s Year: 2001